US Clinical Trials Support Services Market - Focused Insights 2023-2028

US Clinical Trials Support Services Market - Focused Insights 2023-2028

REPORT OVERVIEW

This report offers market size & forecast data for the US clinical trial support services market. The revenue generated from services offered for phase 1, phase II, phase III & phase IV stages of development are included in the report. Revenue generated from services offered for discovery, pre-clinical, and phase 0 stages of development are excluded from the report. This report provides a comprehensive and current market scenario of the US clinical trial support services market, including the US clinical trial support services market size, anticipated market forecast, relevant market segmentations, and industry trends.

The study considers a detailed scenario of the present clinical trial support services market and its market dynamics for 2023−2028 in the US. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

Clinical Trial Support Services provides a full range of clinical trial services, including but not limited to trial management, recruitment, clinical measures, data entry, telephone, and in-person follow-up. Most pharmaceutical and biotechnology firms do not have the expertise, time, or infrastructure to carry out clinical trials and, therefore, hire other companies to conduct the same.

KEY HIGHLIGHTS

• In the US, the clinical trial support services market was valued at $7.43 billion in 2022 and is expected to reach $10.44 billion by 2028, growing at a CAGR of 5.84%. The demand for clinical trial support services market is on the rise due to multiple factors, including a surge in R&D activities, the high prevalence of chronic diseases, and the adoption of clinical trial support services.
• By Service type, the site management systems accounted for the highest share of 43.03% in 2022 and is projected to grow at the highest CAGR of 5.37% during the forecast period. The increasing demand for site management systems is due to the rising disease burden, increasing prevalence of chronic diseases, and increasing number of clinical trials.
• By Phase, the Phase III segment accounted for the highest share of 45.55% in 2022 and is projected to grow at the highest CAGR of 6.19% during the forecast period. The rise in the number of clinical trials and the high prevalence of chronic diseases, among others, is expected to contribute to the growth of the overall clinical trial support services market.
• In End-user type, the pharma & biotech companies segment accounted for the highest share of 66.32% in 2022 and is projected to grow at the highest CAGR of 5.50% during the forecast period. The high prevalence of chronic diseases and increasing R&D expenditure by pharma & biotech companies will drive the growth of the market
• By Application, the cancer segment accounted for the highest share of 33.64% in 2022 and is projected to grow at the highest CAGR of 6.14% during the forecast period. The rising prevalence of cancer conditions, demand for clinical trials, and constant increase in cancer patients are some of the factors that propel the segment growth.
• Charles River Laboratories, IQVIA Inc, Icon plc, Labcorp Drug Development, and Syneos Health are some of the leading players currently dominating the US clinical trial support services market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the clinical trial support services market.

VENDORS LIST

• Charles River Laboratories
• IQVIA Inc
• Icon plc
• Labcorp Drug Development
• Syneos Health
• Thermo Fisher Scientific
• WuXi AppTec
• Paraxel
• Advanced Clinical
• ProtaGene
• Curia Global
• Aixial Group
• Cromos Pharma
• Criterium
• KCR S.A.
• Medpace
• Medelis
• Worldwide Clinical Trials
• Sofpromed
• Veristat

REPORT HIGHLIGHTS

PRODUCT SEGMENTATION & FORECAST

• By Service

▪ Site Management

▪ Recruitment Management

▪ Data Management

▪ Institutional Review Board

▪ Others

• By Phase

▪ Phase III

▪ Phase II

▪ Phase IV

▪ Phase I

• End-user

▪ Pharmaceutical & Biotech Companies

▪ Medical Device Companies

▪ Others

• By Application

▪ Cancer

▪ Cardiovascular Diseases

▪ Nervous System Diseases

▪ Infectious Diseases

▪ Musculo-skeletal Diseases

▪ Gastroenterology Diseases

▪ Others



MARKET STRUCTURE

• Market Dynamics
• Competitive Landscape of Clinical Trial Support Services Market
• Key Vendors
• Other Prominent Vendors

APPENDIX

• Research Methodology
• Abbreviations
• About Arizton